Background: Auditing is an important tool to identify practice variation and 'best practices'. The
INTRODUCTION
Monitoring quality of care has a long history in surgical practice. 1, 2 The goal of measuring outcomes is usually to determine the optimal treatment by comparing interventions. Clinical auditing, however, aims at measuring and comparing outcomes of doctors or hospitals for a specific patient population. These results can then be used to improve current practice and increase transparency, which is increasingly demanded by society. Clinical auditing is increasingly being implemented throughout surgery, and prominent initiatives such as the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) have already improved outcomes for patients. 3, 4 Auditing is relevant especially to areas of surgery where there is much inter-hospital variation: in pancreatic surgery, differences in mortality between hospitals are among the highest. Patient outcomes may be divided into short-term (e.g. in-hospital mortality) or long-term (e.g. survival), subjective (e.g. quality of life), and intermediate (e.g. intra-operative blood loss) outcomes.
Identifying the most important performance indicators is the main challenge of setting up an audit.
Performance indicators should be relevant for the patient, have unambiguous definitions, and data collection should be straightforward. Fair comparison of performance indicators across hospitals (i.e. benchmarking) requires adjustment for differences in baseline characteristics. Therefore, baseline characteristics associated with performance indicators (e.g., tumor stage when comparing survival) should also be collected in the audit. 6, 7 Data collection for the mandatory Dutch Pancreatic Cancer Audit (DPCA) started in 2013. All patients undergoing surgical exploration for a suspected pancreatic or periampullary tumor in the Netherlands are included, as imposed by the Dutch Healthcare Inspectorate. 8 The DPCA aims to improve patient outcomes after pancreatic surgery by reducing practice variation and stimulating 'best practices'. In this study we describe the design, results, and validation of a nationwide evidence-based surgical audit in pancreatic cancer surgery. Medical Center in Utrecht (the Netherlands).
METHODS

Design of the audit
Next, the selection of the most frequently identified performance indicators and independent case-mix factors was based on a consensus process. The identified performance indicators and case-mix factors were first discussed with (inter)national field experts (see acknowledgements).
The data model was developed hereafter in a plenary consensus with all members of the Dutch Pancreatic Cancer Group; the national multidisciplinary working group on pancreatic tumors with active members from all involved medical specialties including surgical oncology, medical-oncology, pathology, gastroenterology, radiology, dietary specialist, and nursing specialist. MRDM, Deventer, the Netherlands). The DPCG scientific committee supervises the data analysis and writes annual auditing reports. The data collected for auditing is also available for scientific research to all DPCA participants.
Results of the audit
Morbidity, mortality, length of stay, and readmission rate was examined in all patients undergoing pancreatic surgery in 2014and 2015, and registered in the DPCA. Mortality was defined as inhospital mortality. Overall morbidity consisted of all surgical and non-surgical morbidity. Major morbidity was defined as any Clavien-Dindo grade III or more morbidity. 10 12 and delayed gastric emptying, 13 or by the International Study Group on Liver Surgery (ISGLS) for bile leakage. 14 Re-interventions (radiologic, surgical or endoscopic), ICU admission, and single-or multi-organ failure were also verified.
Each year, the Dutch Healthcare Inspectorate requests the number of performed pancreatoduodenectomies from each Dutch center regardless of indication (including benign disease, which is excluded from the DPCA). These data are published publicly online and were crosschecked to the number of pancreatoduodenectomies in the audit in 2014 and 2015. 15 3
Statistical analysis
Dichotomous data were presented as proportions. Continuous data were presented as medians with interquartile range (IQR). Differences in binary postoperative outcomes were analyzed using Chi-square test. Unpaired t-test and one-way ANOVA were used in the comparison of postoperative length of stay between two groups, or more than two groups, respectively. P values of less than 5%
were considered significant. Statistical analysis was performed using SPSS Statistics for Windows (Version 20.0; IBM, Armonk, NY).
RESULTS
Performance indicators and case-mix factors
The literature search retrieved 16 RCT's, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] and three large case series of pancreatic surgery. Postoperative outcomes following pancreatic resection for suspected malignancy are shown in Table 2 as well. In-hospital mortality following pancreatic resection was 3.6%. There was a significantly higher mortality among males (4.6%) compared to females (2.4%, p = 0.04). There was a significantly higher mortality with increasing age categories: 1.7% in patients aged <65
years, 4.0% in patients aged 65-74 years, and 6.5% inpatients aged ≥75 years (p < 0.001). Mortality was significantly higher in patients with periampullary carcinoma (6.2%) compared to patients with pancreatic adenocarcinoma (3.2%), or another diagnosis (2.3%, p = 0.02).
Overall morbidity rate was 57.6% and the rate of Clavien-Dindo grade ≥ III morbidity was 27.3%. 
Data verification
In total, 42 179 variables were cross-checked with medical charts. A total of 1162 (2.8%) variables recorded in the audit was missing or different then recorded in the medical charts ( Table 3 ). Type of procedure was incorrectly registered in 9.5% of cases, involving mainly whether or not the pylorus was preserved. In-hospital mortality was correctly registered in all patients.
Crosscheck with the inspectorate data revealed that >90% of performed pancreatoduodenectomies (1347 registered in the audit, compared to 1448 reported to the inspectorate) were included in the first two registration years. The nationwide in-hospital mortality rate after PD was 4.1%. Few other studies report populationbased outcomes after pancreatic surgery. A NSQIP study reported 30-day mortality of 2.9% for PD. 33 Two notable other large population based reports from the U.S. reported in-hospital mortality rates of 6.6% and 7.9% for PD. after PD of 2.1% and 3.3%, respectively. 41, 42 The relatively low mortality rate in the Netherlands, as compared to for example Germany, may be explained by the centralization of pancreatic surgery in the Netherlands which has lowered mortality. 43 The rate of major morbidity (Clavien-Dindo score above III) in this study was 27.3%. Other registries show similar rates although different definitions were used. NSQIP has reported major morbidity rate of 24%. 44 Defined as Modified Accordion severity grade ≥3, in another study this was 27.8%. 45 Beside the obvious implications, postoperative morbidity also dominates costs. 46 The nationwide rate of grade B/C POPF was 12.9% (13.0% after pancreatoduodenectomy), comparable to other studies. 47, 48 As of 2017, the DPCA will register the new definition and grading system of POPF. Europe, or 30-40 days in Asia. 38, 40, 42, 50, 51 Enhanced recovery after surgery (ERAS) programs are rapidly being implemented worldwide. 52 Implementation of ERAS did not appear to be related to increased readmission rates; 16% in this study versus 20% in previous database studies. 36, 49 Length of postoperative stay depends not only on the quality of care but also on local, cultural, and regional aspects.
In the current study, data on mortality was 100% correctly registered. Data accuracy was 97.2%
for other indicators and covariates. These results compare favorably to other equivalents. 53, 54 The high accuracy at validation is important because of potential criticism that data are entered in the DPCA by health care providers rather than by independent data managers. To guarantee high quality data in the future a formal data validation program will be launched involving trained independent data managers.
The DPCA will be further improved in the coming years. Patients will be involved in the selection of indicators, comparable to the initiatives of the International Consortium for Health Outcomes Measurement (ICHOM). 55 Registration burden will be reduced by implementation of synoptic reports which we have developed for operation note, discharge letter, and pathology and radiology reports. 9 Real-time feedback to individual health care providers of their outcomes in will be introduced. Data sharing initiatives will allow the DPCA to be merged with the National 
